The HIF2α Inhibitor Belzutifan Shows Signs of Efficacy in Kidney Cancer

Authors:

Published: 2021-04-30

DOI: 10.1158/2159-8290.cd-rw2021-062

Source: Full article

---

Abstract

Abstract